KRYS vs GILD: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Gilead Sciences Inc in 2026
KRYS
Krystal Biotech Inc
$270.00
GILD
Gilead Sciences Inc
$140.45
Key Metrics Comparison
| Metric | KRYS | GILD | Winner |
|---|---|---|---|
| Market Cap | $7.87B | $172.56B | GILD |
| P/E Ratio | 39.04 | 20.51 | GILD |
| EPS (TTM) | $6.85 | $6.78 | KRYS |
| Revenue Growth | 0.2% | 0.0% | KRYS |
| Gross Margin | 94.1% | 78.8% | KRYS |
Analyze KRYS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or GILD a better investment?
Comparing KRYS and GILD: Krystal Biotech Inc has a market cap of $7.87B while Gilead Sciences Inc has $172.56B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and GILD?
KRYS (Krystal Biotech Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or GILD?
Based on P/E ratios, GILD trades at a lower multiple (20.5x vs 39.0x).
Which is growing faster: KRYS or GILD?
KRYS has higher revenue growth at 0.2% vs 0.0% for GILD.
Which company is more profitable: KRYS or GILD?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 78.8% for GILD.
Which is the larger company: KRYS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $172.56B compared to $7.87B for KRYS.
Should I buy KRYS or GILD in 2026?
Both KRYS and GILD have investment merit. KRYS trades at $270.00 while GILD trades at $140.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and GILD stock?
Key differences: Market Cap ($7.87B vs $172.56B), P/E Ratio (39.0x vs 20.5x), Revenue Growth (0.2% vs 0.0%), Gross Margin (94.1% vs 78.8%).